id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-D-1307-0036,FDA,FDA-2016-D-1307,"Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers; Revised Draft Guidance for Industry; Availability",Notice,Notice of Availability,2026-06-03T04:00:00Z,2026,6,2026-06-03T04:00:00Z,,2026-06-03T18:20:20Z,2026-11060,0,0,09000064b930af49
FDA-2016-D-1307-0037,FDA,FDA-2016-D-1307,"Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers; Revised Draft Guidance for Industry",Other,Guidance,2026-06-03T04:00:00Z,2026,6,2026-06-03T04:00:00Z,2026-08-04T03:59:59Z,2026-06-03T18:25:02Z,,1,0,09000064b930bcc1
FDA-2016-D-1307-0035,FDA,FDA-2016-D-1307,Drug and Device Manufacturer Communications With Payors Formulary Committees and Similar Entities - Questions and Answers - Guidance for Industry and Review Staff,Other,Guidance,2018-11-02T04:00:00Z,2018,11,2018-11-02T04:00:00Z,,2024-11-12T22:48:39Z,,1,0,0900006483884165
FDA-2016-D-1307-0034,FDA,FDA-2016-D-1307,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2018-10-11T04:00:00Z,2018,10,2018-10-11T04:00:00Z,,2018-10-11T15:03:58Z,2018-22101,0,0,09000064837c0367
FDA-2016-D-1307-0028,FDA,FDA-2016-D-1307,"Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers; Guidance for Industry; Availability",Notice,Notice of Availability,2018-06-13T04:00:00Z,2018,6,2018-06-13T04:00:00Z,2018-07-14T03:59:59Z,2018-06-15T01:05:45Z,2018-12632,0,0,0900006483404831
FDA-2016-D-1307-0029,FDA,FDA-2016-D-1307,Drug and Device Manufacturer Communications With Payors Formulary Committees and Similar Entitites - Questions and Answers,Other,Guidance,2018-06-13T04:00:00Z,2018,6,2018-06-13T04:00:00Z,2018-07-14T03:59:59Z,2024-11-12T20:03:02Z,,1,0,0900006483404f99
FDA-2016-D-1307-0002,FDA,FDA-2016-D-1307,"Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers",Other,Guidance,2017-01-19T05:00:00Z,2017,1,2017-01-19T05:00:00Z,,2019-08-21T18:59:26Z,,0,0,0900006482485b6e
FDA-2016-D-1307-0001,FDA,FDA-2016-D-1307,"Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers; Draft Guidance for Industry and Review Staff; Availability",Notice,Notice of Availability,2017-01-19T05:00:00Z,2017,1,2017-01-19T05:00:00Z,2017-04-20T03:59:59Z,2017-04-20T01:03:11Z,2017-01011,0,0,090000648248556a